2 active not recruiting. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Active not recruiting 2 |
Follow Atrophy: new trials by email Literature Review of Atrophy trials Research Report on Atrophy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| GLP-1s to Enhance Lasting Optimal Weight Tirzepatide - Obesity | Phase 4 | Active not recruiting | Wake Forest University Health Sciences | 40 | 2025-07-07 | 2026-10-02 |
| The Effect of Intradialytic Parenteral Nutrition on Nutritional Status and Quality of Life in Hemodialysis Patients Olimel N12, Glucose IV - End Stage Renal Disease, Malnutrition | Phase 4 | Active not recruiting | Erasmus Medical Center | 166 | 2019-09-16 | 2026-02-12 |
Kidney Failure, Chronic (1) · Malnutrition (1) · Muscular Atrophy (1) · Obesity (1) · Sarcopenia (1) · Weight Loss (1)
Nervous System Diseases (2) · Neurologic Manifestations (2) · Neuromuscular Manifestations (2) · Nutrition Disorders (2) · Nutritional and Metabolic Diseases (2) · Pathological Conditions, Anatomical (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Body Weight (1) · Body Weight Changes (1) · Chronic Disease (1) · Disease Attributes (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1)
1-((2-hydroxyethyl)amino)-2-amino-1,2-dideoxyglucose triphenyltin(IV) (1) · Tirzepatide (1)
Erasmus Medical Center (1) · Wake Forest University Health Sciences (1)
Netherlands (1) · United States (1)
Denise Houston, PhD (1) · Ewout J Hoorn, MD PhD (1)
2018 (1)